Tilray IncTLRY
▼ NegativeCapitalrelevance
EPS estimate decline of 105% YoY and negative earnings outlook
Impact on stocks 1
Health Care
Tilray IncTilray Brands shares fall 2.96%, underperforming broader market
Earnings
Tilray Brands shares closed at $4.59, a decline of 2.96% that was steeper than the S&P 500's 0.37% loss. The stock has dropped 10.59% over the past month, underperforming both the Medical sector's 1.49% gain and the S&P 500's 2.02% advance. Ahead of its upcoming financial release, the Zacks Consensus Estimate projects an EPS of negative $0.01, down 105% from the prior-year quarter, on net sales of $268.17 million, a 19.43% increase. For the full year, analysts expect earnings of negative $0.58 per share and revenue of $885.3 million, representing changes of negative 680% and positive 7.79%, respectively. Tilray Brands currently carries a Zacks Rank of 3, or Hold, with no change in the consensus EPS estimate over the past month.
Tilray IncEPS estimate decline of 105% YoY and negative earnings outlook